XML 79 R40.htm IDEA: XBRL DOCUMENT v3.21.1
Collaborative Agreements (Details Narrative) - USD ($)
12 Months Ended
Feb. 25, 2019
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2015
Number of stock options vested   1,104,044 584,895  
Research and development expense   $ 699,797 $ 807,947  
Research Agreements [Member]        
Research and development expense   $ 0 $ 63,905  
Stock Options [Member]        
Number of stock options vested 59,900      
University of Toronto [Member]        
Share-based compensation stock options, grants       25,000
Share-based compensation weighted average exercise price       $ 1.00
Share-based payment award, expiration period       10 years
Options expiration date, description       Exercisable over a ten year period which ends on April 1, 2022.
Dr. David Lovejoy [Member] | Stock Options [Member]        
Share-based compensation stock options, grants   553,299    
Share-based compensation weighted average exercise price   $ 1.00    
Options expiration date, description   These have an exercise price of $1.00, $1.25 or 1.75 and are exercisable over ten or thirteen year periods which end either on March 30, 2021, December 1, 2022, April 15, 2026, March 1, 2027, October 16, 2027 or on February 13, 2030.    
Number of stock options vested   527,570    
Dr. David Lovejoy [Member] | Stock Options [Member] | Minimum [Member]        
Share-based compensation weighted average exercise price   $ 1.25    
Share-based payment award, expiration period   10 years    
Dr. David Lovejoy [Member] | Stock Options [Member] | Maximum [Member]        
Share-based compensation weighted average exercise price   $ 1.75    
Share-based payment award, expiration period   13 years